ANGELIQUE VIDRINE: Open Payments
NPI 1598115230 · WASHINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 4 companies in 2025. Trend: 2023 $155 · 2024 $98 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: IBSRELA, MOUNJARO, Ozempic, ZEPBOUND, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
